Loading clinical trials...
Loading clinical trials...
A Relative Bioavailability Study of Moexipril HCL/Hydrochlorothiazide 15/25 mg Tablets Under Fasting Conditions
Conditions
Interventions
Moexipril HCl/hydrochlorothiazide 15/25 mg tablets
UNIRETIC® 15/25 mg tablets
Locations
2
United States
Gateway Medical Research, Inc.
Saint Charles, Missouri, United States
Bioassay Laboratory, Inc.
Houston, Texas, United States
Start Date
October 1, 2003
Primary Completion Date
November 1, 2003
Completion Date
November 1, 2003
Last Updated
August 20, 2024
NCT00104325
NCT07470866
NCT07388667
NCT07221448
NCT06637865
NCT07118891
Lead Sponsor
Teva Pharmaceuticals USA
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions